| Affiliation: | 1. Division of Hematology and Bone Marrow Transplantation, Hematology Department, Chaim Sheba Medical Center, Ramat Gan, Israel;2. Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel;1. Department of Obstetrics and Gynaecology, Division of Gynecologic Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium, European Union;2. Aalborg University Hospital, Aalborg, Denmark;3. Herlev University Hospital, Herlev, Denmark;4. Department of Oncology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;5. GSO Hamburg, Germany;6. Karyopharm Therapeutics Newton, MA, USA;1. Department of Pharmacy, Boston Medical Center, Boston, MA;2. Amyloidosis Center, Boston University School of Medicine, Boston, MA;3. Albany College of Pharmacy and Health Sciences, Albany, NY;1. Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen), City of Hope Cancer Center, Phoenix, AZ;2. Multiple Myeloma Program, Dana-Farber Cancer Institute, Boston, MA;3. Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;4. Winship Cancer Institute, Emory University, Atlanta, GA;5. Medical Director for the University of Alabama Blood and Marrow Transplantation Program, University of Alabama at Birmingham, Birmingham, AL;6. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;7. Division Chief, Multiple Myeloma, Hackensack Meridian Health, Hackensack, NJ;8. Division of Hematology and Oncology, Department of Medicine, Columbia University, New York, NY |
